[Ibandronate].
Yamada
Takahito
T
Clinical Research Department 4, Chugai Pharmaceutical Co., Ltd.
Suzuki
Mamoru
M
Kuwahara
Toshikazu
T
Tanaka
Yushiro
Y
D000818:Animals; D015519:Bone Density; D001862:Bone Resorption / Q000517:prevention & control; D017326:Clinical Trials, Phase III as Topic; D004164:Diphosphonates / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D000077557:Ibandronic Acid; D010010:Osteoclasts / Q000187:drug effects; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D010349:Patient Compliance; D016032:Randomized Controlled Trials as Topic; D016103:Spinal Fractures / Q000209:etiology / Q000517:prevention & control
D004164:Diphosphonates; D000077557:Ibandronic Acid